Clinical Trial Details
| Trial ID: | L0329 |
| Source ID: | NCT00646932 |
| Associated Drug: | Paricalcitol |
| Title: | Paricalcitol Injection Phase II Trial |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Chronic Kidney Disease |
| Interventions: | DRUG: paricalcitol|DRUG: paricalcitol|DRUG: paricalcitol|DRUG: paricalcitol |
| Outcome Measures: | Primary: Pharmacokinetics, 2 weeks | Secondary: Safety, 2 weeks |
| Sponsor/Collaborators: | Sponsor: Abbott |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 25 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: |
| Start Date: | 2005-11 |
| Completion Date: | |
| Results First Posted: | |
| Last Update Posted: | 2008-03-31 |
| Locations: | Gunma, Japan|Hokkaido, Japan|Ibaraki, Japan|Kagoshima, Japan|Kumamoto, Japan|Nagano, Japan|Nagasaki, Japan|Saitama, Japan|Shizuoka, Japan|Tokyo, Japan |
| URL: | https://clinicaltrials.gov/show/NCT00646932 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|